Spring til hovednavigation Spring til søgning Spring til hovedindhold

Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis

  • Solène Evrard
  • , Olivier Bluteau
  • , Micheline Tulliez
  • , Philippe Rameau
  • , Patrick Gonin
  • , Eva Zetterberg
  • , Jan Palmblad
  • , Arnaud Bonnefoy
  • , Jean-Luc Villeval
  • , William Vainchenker
  • , Stéphane Giraudier
  • , Orianne Wagner-Ballon
    20 Citationer (Scopus)

    Abstract

    Transforming growth factor-β1 (TGF-β1) is the most important cytokine involved in the promotion of myelofibrosis. Mechanisms leading to its local activation in the bone marrow environment remain unclear. As a recent study has highlighted the role of thrombospondin-1 (TSP-1) in platelet-derived TGF-β1 activation, we investigated the role of TSP-1 in the TPO(high) murine model of myelofibrosis. Two groups of engrafted mice, WT TPO(high) and Tsp-1-null TPO(high), were constituted. All mice developed a similar myeloproliferative syndrome and an increase in total TGF-β1 levels in the plasma and in extracellular fluids of marrow and spleen. Surprisingly, we were able to detect the active form of TGF-β1 in Tsp-1-null TPO(high) mice. Accordingly, these mice developed marrow and spleen fibrosis, with intriguingly a higher grade than in WT TPO(high) mice. Our results show that TSP-1 is not the major activator of TGF-β1 in TPO-induced myelofibrosis, suggesting the contribution of another mechanism in the megakaryocyte/platelet compartment.
    OriginalsprogEngelsk
    TidsskriftBlood
    Vol/bind117
    Udgave nummer1
    Sider (fra-til)246-9
    Antal sider4
    ISSN0006-4971
    DOI
    StatusUdgivet - 6 jan. 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis'. Sammen danner de et unikt fingeraftryk.

    Citationsformater